BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22411879)

  • 1. Global Immunization Vision and Strategy (GIVS): a mid-term analysis of progress in 50 countries.
    Kamara L; Lydon P; Bilous J; Vandelaer J; Eggers R; Gacic-Dobo M; Meaney W; Okwo-Bele JM
    Health Policy Plan; 2013 Jan; 28(1):11-9. PubMed ID: 22411879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
    Chauke-Moagi BE; Mumba M
    Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global routine vaccination coverage, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(42):1367-71. PubMed ID: 21030941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in global measles control and mortality reduction, 2000-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(47):1237-41. PubMed ID: 18046301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance.
    Lee LA; Franzel L; Atwell J; Datta SD; Friberg IK; Goldie SJ; Reef SE; Schwalbe N; Simons E; Strebel PM; Sweet S; Suraratdecha C; Tam Y; Vynnycky E; Walker N; Walker DG; Hansen PM
    Vaccine; 2013 Apr; 31 Suppl 2():B61-72. PubMed ID: 23598494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric disease burden and vaccination recommendations: understanding local differences.
    Gentile A; Bhutta Z; Bravo L; Samy AG; Garcia RD; Hoosen A; Islam T; Karimi A; Salem M; Simasathien S; Sohail A; Watanaveeradej V; Wiedenmayer K; Schmitt HJ
    Int J Infect Dis; 2010 Aug; 14(8):e649-58. PubMed ID: 20181506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS).
    Brown DW; Burton A; Gacic-Dobo M; Karimov RI; Vandelaer J; Okwo-Bele JM
    BMC Public Health; 2011 Oct; 11():806. PubMed ID: 21999521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in global measles control and mortality reduction, 2000-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(48):1303-6. PubMed ID: 19052529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of new vaccine introduction on the coverage of existing vaccines: a cross-national, multivariable analysis.
    Shearer JC; Walker DG; Risko N; Levine OS
    Vaccine; 2012 Dec; 30(52):7582-7. PubMed ID: 23099327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
    Verma R; Khanna P; Chawla S; Bairwa M; Prinja S; Rajput M
    Hum Vaccin; 2011 Nov; 7(11):1158-60. PubMed ID: 22048118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunizing the children of the world: progress and prospects.
    Henderson RH; Keja J; Hayden G; Galazka A; Clements J; Chan C
    Bull World Health Organ; 1988; 66(5):535-43. PubMed ID: 3264762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global routine vaccination coverage, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1520-2. PubMed ID: 22071590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward measles mortality reduction and elimination--Eastern Mediterranean Region, 1997-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):262-7. PubMed ID: 18340334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [WHO spearheads global initiative to eradicate hepatitis B].
    Sylvan S
    Lakartidningen; 2000 Aug; 97(35):3738-40. PubMed ID: 11016226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global routine vaccination coverage, 2011.
    Centers for Disease Control and Prevention
    MMWR Morb Mortal Wkly Rep; 2012 Nov; 61(43):883-5. PubMed ID: 23114256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Measles Initiative: moving toward measles eradication.
    Christie AS; Gay A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S14-7. PubMed ID: 21666155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global measles mortality, 2000-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(47):1321-6. PubMed ID: 19959985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.